v3.26.1
Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Jul. 31, 2026
Jul. 25, 2025
Income Statement [Abstract]    
Net sales $ 9,756 $ 8,578
Costs and expenses:    
Cost of products sold, excluding amortization of intangible assets 3,416 3,001
Research and development expense 771 726
Selling, general, and administrative expense 3,198 2,806
Amortization of intangible assets 412 459
Restructuring charges, net 72 45
Certain litigation charges, net 0 27
Other operating expense (income), net 123 70
Operating profit 1,764 1,445
Other non-operating expense (income), net (190) (33)
Interest expense, net 186 176
Income before income taxes 1,769 1,302
Income tax provision 289 255
Net income 1,479 1,047
Net income attributable to noncontrolling interests (9) (7)
Net income attributable to Medtronic $ 1,470 $ 1,040
Basic earnings per share (in dollars per share) $ 1.15 $ 0.81
Diluted earnings per share (in dollars per share) $ 1.14 $ 0.81
Basic weighted average shares outstanding (in shares) 1,279.8 1,281.6
Diluted weighted average shares outstanding (in shares) 1,285.1 1,287.1